Imipenem/cilastin dosage during acute renal failure and hemofiltration

Saved in:

Bibliographic Details
Published in	Intensive care medicine Vol. 21; no. 10; p. 863
Main Authors	Dehne, M G, Kroh, U F
Format	Journal Article
Language	English
Published	United States 01.10.1995
Subjects	Acute Kidney Injury - blood Acute Kidney Injury - therapy Cilastatin - pharmacokinetics Cilastatin - therapeutic use Cilastatin, Imipenem Drug Combination Drug Combinations Drug Monitoring - methods Drug Therapy, Combination - pharmacokinetics Drug Therapy, Combination - therapeutic use Hemofiltration Humans Imipenem - pharmacokinetics Imipenem - therapeutic use
Online Access	Get more information

Cover

Loading…

Author	Dehne, M G Kroh, U F
Author_xml	– sequence: 1 givenname: M G surname: Dehne fullname: Dehne, M G – sequence: 2 givenname: U F surname: Kroh fullname: Kroh, U F
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/8557879$$D View this record in MEDLINE/PubMed
BookMark	eNotj71OwzAURj0UlbawsCP5BUJt5_pvhIpApUosMFeufV2MEidykoG3pxKdvuFI5-hbk0XuMxLywNkTZ0xvXxrGNWNWw4KsWA2iAgXilqzH8YddkJJ8SZZGSm20XZFm36UBM3Zbn1o3TinT0I_ujDTMJeUzdX6ekBbMrqXRpXYuSF0O9Bu7PqZ2Km5Kfb4jN9G1I95fd0O-mtfP3Xt1-Hjb754PlRdGTFVUl7yVUQfPgw0YwAgAobEGsMoy47UE9EpisIJ7rcCyyIypkeuTkkpsyOO_d5hPHYbjUFLnyu_x-kf8AYf0Sxw
CitedBy_id	crossref_primary_10_1016_S0009_9236_99_70121_9 crossref_primary_10_1007_s11096_005_1636_x crossref_primary_10_1007_s40262_020_00865_3 crossref_primary_10_2165_00003088_200039030_00002
ContentType	Journal Article
DBID	CGR CUY CVF ECM EIF NPM
DOI	10.1007/BF01700974
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid)
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database
DeliveryMethod	no_fulltext_linktorsrc
Discipline	Medicine
ExternalDocumentID	8557879
Genre	Letter Clinical Trial Controlled Clinical Trial
GroupedDBID	--- -53 -5E -5G -BR -EM -Y2 -~C .55 .86 .GJ .VR 06C 06D 0R~ 0VY 199 1N0 1SB 2.D 203 28- 29J 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67Z 6NX 78A 7RV 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAEOY AAHNG AAIAL AAJBT AAJKR AANXM AANZL AAQQT AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAWTL AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHFT ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABOCM ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABUWZ ABWNU ABXPI ACAOD ACBXY ACDTI ACGFO ACGFS ACHSB ACHVE ACHXU ACIHN ACIPQ ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACREN ACUDM ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEAQA AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFFNX AFJLC AFKRA AFLOW AFQWF AFRAH AFWTZ AFYQB AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJOOF AJRNO AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARMRJ AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BKEYQ BPHCQ BVXVI CAG CCPQU CGR COF CS3 CSCUP CUY CVF DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS ECM EIF EIOEI EJD EMB EMOBN EN4 ESBYG EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IAO IEA IHE IHR IJ- IKXTQ IMOTQ INH IOF ITC ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z J5H JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM LMP M1P M4Y MA- MJL N2Q N9A NAPCQ NB0 NDZJH NPM NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 WOW X7M YCJ YLTOR Z45 Z5O Z7U Z7X Z82 Z83 Z86 Z87 Z8O Z8V Z8W Z8Z Z91 ZGI ZMTXR ZOVNA ~EX
ID	FETCH-LOGICAL-c282t-f665195f7dc1d9ded4824427e34496908c754ec65ed921c76490f0883e17b6562
ISSN	0342-4642
IngestDate	Wed Oct 16 00:50:30 EDT 2024
IsPeerReviewed	true
IsScholarly	true
Issue	10
Language	English
LinkModel	OpenURL
MergedId	FETCHMERGED-LOGICAL-c282t-f665195f7dc1d9ded4824427e34496908c754ec65ed921c76490f0883e17b6562
PMID	8557879
ParticipantIDs	pubmed_primary_8557879
PublicationCentury	1900
PublicationDate	1995-Oct
PublicationDateYYYYMMDD	1995-10-01
PublicationDate_xml	– month: 10 year: 1995 text: 1995-Oct
PublicationDecade	1990
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Intensive care medicine
PublicationTitleAlternate	Intensive Care Med
PublicationYear	1995
SSID	ssj0017651
Score	1.5310895
SourceID	pubmed
SourceType	Index Database
StartPage	863
SubjectTerms	Acute Kidney Injury - blood Acute Kidney Injury - therapy Cilastatin - pharmacokinetics Cilastatin - therapeutic use Cilastatin, Imipenem Drug Combination Drug Combinations Drug Monitoring - methods Drug Therapy, Combination - pharmacokinetics Drug Therapy, Combination - therapeutic use Hemofiltration Humans Imipenem - pharmacokinetics Imipenem - therapeutic use
Title	Imipenem/cilastin dosage during acute renal failure and hemofiltration
URI	https://www.ncbi.nlm.nih.gov/pubmed/8557879
Volume	21
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1LS8NAEMcXqyi9iK_imz14jeax2c0eRS1VaU8t9FaSzYQW7IOSk5_e2c0mTavi4xJCFkK7v2Qys_ufGUJuwE1lFAfgAHgYoKDT68QqwKg1yZJQC8Z8U2e72-OdAXsZhsOy0bbNLsmTW_X-ZV7Jf6jiNeSqs2T_QLa6KV7Ac-SLRySMx18xfp5OFmirEGlbTdANzrW0da6lYlX6odI6gCVonzOLJ2_ldsEYprpXt62ZW_dQV5p2Iwrb3Ht_hHGxBtpddeV6Xc7N4szAyoRTm1UXVnK0KnmK-Q7jbM0w-l79AXBrZi4qjNIn8-uWonJd9U8W7XdqHBZTAyIKtZmQPw5uFMK2Iw3SEJG2aD29LmP3iwQ3jTarv7FeiNb-mibZtffYiCGML9E_IPs2CKD3BdFDsgWzI7LXtVN9TNol2LsSKy2w0gIrNVipwUotVopY6TrWEzJoP_UfOo5teOEojHxzJ-NcF_vJRKq8VKaQsgi9L19AwJjk0o2UCBkoHkIqfU8JzqSb4WciAE8k6Jj7LbI9m8_glFARizSJgwAkB-bHSSJ1RiN4MlMQCRGekVYxA6NFUdVkZKfm_LuBC9JcPTmXZCfDlwiu0CPLk2sD4wMGujLw
link.rule.ids	783
linkProvider	National Library of Medicine
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Imipenem%2Fcilastin+dosage+during+acute+renal+failure+and+hemofiltration&rft.jtitle=Intensive+care+medicine&rft.au=Dehne%2C+M+G&rft.au=Kroh%2C+U+F&rft.date=1995-10-01&rft.issn=0342-4642&rft.volume=21&rft.issue=10&rft.spage=863&rft_id=info:doi/10.1007%2FBF01700974&rft_id=info%3Apmid%2F8557879&rft_id=info%3Apmid%2F8557879&rft.externalDocID=8557879
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0342-4642&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0342-4642&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0342-4642&client=summon